The goal of clinical therapy for most asthma and COPD patients is to prevent lung damage and control symptoms so that these do not interfere with daily activities. In this digest we are focusing on key events by the Pharma companies in COPD and Asthma only. This also gives us an understanding of how each of them are trying to increase their footprint in respiratory diseases